These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8481613)

  • 21. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The natural history of dementia in Down's syndrome.
    Evenhuis HM
    Arch Neurol; 1990 Mar; 47(3):263-7. PubMed ID: 2138013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.
    Hyman BT; West HL; Rebeck GW; Lai F; Mann DM
    Arch Neurol; 1995 Apr; 52(4):373-8. PubMed ID: 7710373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome.
    Deb S; Braganza J; Norton N; Williams H; Kehoe PG; Williams J; Owen MJ
    Br J Psychiatry; 2000 May; 176():468-72. PubMed ID: 10912224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-infarct dementia in Down's syndrome.
    Collacott RA; Cooper SA; Ismail IA
    J Intellect Disabil Res; 1994 Apr; 38 ( Pt 2)():203-8. PubMed ID: 8193456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study.
    Yang Q; Rasmussen SA; Friedman JM
    Lancet; 2002 Mar; 359(9311):1019-25. PubMed ID: 11937181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olfactory dysfunction in Down's Syndrome.
    Murphy C; Jinich S
    Neurobiol Aging; 1996; 17(4):631-7. PubMed ID: 8832638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alzheimer's disease in mongoloid idiocy (Down's trisomy)].
    Piessens FP; Overweg J
    Ned Tijdschr Geneeskd; 1971 Nov; 115(48):2018-20. PubMed ID: 4260153
    [No Abstract]   [Full Text] [Related]  

  • 29. Onset of dementia is associated with age at menopause in women with Down's syndrome.
    Schupf N; Pang D; Patel BN; Silverman W; Schubert R; Lai F; Kline JK; Stern Y; Ferin M; Tycko B; Mayeux R
    Ann Neurol; 2003 Oct; 54(4):433-8. PubMed ID: 14520653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical and neurobehavioral course of Down syndrome and dementia with or without new-onset epilepsy.
    Gholipour T; Mitchell S; Sarkis RA; Chemali Z
    Epilepsy Behav; 2017 Mar; 68():11-16. PubMed ID: 28109983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia.
    Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Raghavan R; Khin-Nu C; Tyrer S; Day K; Crook R
    Neuroreport; 1994 Dec; 5(18):2583-5. PubMed ID: 7696609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down's syndrome and Alzheimer's dementia: defining an association.
    Heston LL
    Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcification of the basal ganglia in Down's syndrome and Alzheimer's disease.
    Mann DM
    Acta Neuropathol; 1988; 76(6):595-8. PubMed ID: 2974228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia.
    Aylward EH; Li Q; Honeycutt NA; Warren AC; Pulsifer MB; Barta PE; Chan MD; Smith PD; Jerram M; Pearlson GD
    Am J Psychiatry; 1999 Apr; 156(4):564-8. PubMed ID: 10200735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diversity of epilepsy in adults with severe developmental disabilities: age at seizure onset and other prognostic factors.
    Brodtkorb E
    Seizure; 1994 Dec; 3(4):277-85. PubMed ID: 7894838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
    Schapiro MB; Haxby JV; Grady CL; Duara R; Schlageter NL; White B; Moore A; Sundaram M; Larson SM; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):766-74. PubMed ID: 2956363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    J Neurol Sci; 1987 Aug; 80(1):79-89. PubMed ID: 2956368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of thyroid stimulating hormone on adaptive behaviour in Down's syndrome.
    Bhaumik S; Collacott RA; Garrick P; Mitchell C
    J Ment Defic Res; 1991 Dec; 35 ( Pt 6)():512-20. PubMed ID: 1839315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.